This report aims to provide a comprehensive presentation of the global market for Angiogenesis Modulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiogenesis Modulators. This report contains market size and forecasts of Angiogenesis Modulators in global, including the following market information:
Global Angiogenesis Modulators Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Angiogenesis Modulators Market Sales, 2018-2023, 2024-2032, (K MT)
Global top five Angiogenesis Modulators companies in 2022 (%)
The global Angiogenesis Modulators market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Angiogenesis Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Angiogenesis Modulators include Celgene Corporation (USA), Eisai (Japan), Amgen, Inc. (USA), Genentech, Inc. (USA), GlaxoSmithKline plc (UK), Bayer Pharma AG (Germany), Bionomics Ltd. (Australia), CASI Pharmaceuticals, Inc. (USA) and AstraZeneca plc (UK), etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Angiogenesis Modulators manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiogenesis Modulators Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K MT)
Global Angiogenesis Modulators Market Segment Percentages, by Type, 2022 (%)
Angiogenesis Inhibitors
Angiogenesis Stimulators
Angiogenin
Others
Global Angiogenesis Modulators Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K MT)
Global Angiogenesis Modulators Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others
Global Angiogenesis Modulators Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K MT)
Global Angiogenesis Modulators Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Angiogenesis Modulators revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Angiogenesis Modulators revenues share in global market, 2022 (%)
Key companies Angiogenesis Modulators sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Angiogenesis Modulators sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celgene Corporation (USA)
Eisai (Japan)
Amgen, Inc. (USA)
Genentech, Inc. (USA)
GlaxoSmithKline plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca plc (UK)
Eli Lilly and Company (USA)
F.Hoffmann-La Roche AG (Switzerland)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Angiogenesis Modulators, market overview.
Chapter 2: Global Angiogenesis Modulators market size in revenue and volume.
Chapter 3: Detailed analysis of Angiogenesis Modulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Angiogenesis Modulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Angiogenesis Modulators capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Angiogenesis Modulators Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Angiogenesis Modulators Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Angiogenesis Modulators Overall Market Size
2.1 Global Angiogenesis Modulators Market Size: 2022 VS 2030
2.2 Global Angiogenesis Modulators Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Angiogenesis Modulators Sales: 2018-2030
3 Company Landscape
3.1 Top Angiogenesis Modulators Players in Global Market
3.2 Top Global Angiogenesis Modulators Companies Ranked by Revenue
3.3 Global Angiogenesis Modulators Revenue by Companies
3.4 Global Angiogenesis Modulators Sales by Companies
3.5 Global Angiogenesis Modulators Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Angiogenesis Modulators Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Angiogenesis Modulators Product Type
3.8 Tier 1, Tier 2 and Tier 3 Angiogenesis Modulators Players in Global Market
3.8.1 List of Global Tier 1 Angiogenesis Modulators Companies
3.8.2 List of Global Tier 2 and Tier 3 Angiogenesis Modulators Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Angiogenesis Modulators Market Size Markets, 2022 & 2030
4.1.2 Angiogenesis Inhibitors
4.1.3 Angiogenesis Stimulators
4.1.4 Angiogenin
4.1.5 Others
4.2 By Type - Global Angiogenesis Modulators Revenue & Forecasts
4.2.1 By Type - Global Angiogenesis Modulators Revenue, 2018-2023
4.2.2 By Type - Global Angiogenesis Modulators Revenue, 2024-2030
4.2.3 By Type - Global Angiogenesis Modulators Revenue Market Share, 2018-2030
4.3 By Type - Global Angiogenesis Modulators Sales & Forecasts
4.3.1 By Type - Global Angiogenesis Modulators Sales, 2018-2023
4.3.2 By Type - Global Angiogenesis Modulators Sales, 2024-2030
4.3.3 By Type - Global Angiogenesis Modulators Sales Market Share, 2018-2030
4.4 By Type - Global Angiogenesis Modulators Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Angiogenesis Modulators Market Size, 2022 & 2030
5.1.2 Breast Cancer
5.1.3 Colorectal Cancer
5.1.4 Lung Cancer
5.1.5 Prostate Cancer
5.1.6 Others
5.2 By Application - Global Angiogenesis Modulators Revenue & Forecasts
5.2.1 By Application - Global Angiogenesis Modulators Revenue, 2018-2023
5.2.2 By Application - Global Angiogenesis Modulators Revenue, 2024-2030
5.2.3 By Application - Global Angiogenesis Modulators Revenue Market Share, 2018-2030
5.3 By Application - Global Angiogenesis Modulators Sales & Forecasts
5.3.1 By Application - Global Angiogenesis Modulators Sales, 2018-2023
5.3.2 By Application - Global Angiogenesis Modulators Sales, 2024-2030
5.3.3 By Application - Global Angiogenesis Modulators Sales Market Share, 2018-2030
5.4 By Application - Global Angiogenesis Modulators Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Angiogenesis Modulators Market Size, 2022 & 2030
6.2 By Region - Global Angiogenesis Modulators Revenue & Forecasts
6.2.1 By Region - Global Angiogenesis Modulators Revenue, 2018-2023
6.2.2 By Region - Global Angiogenesis Modulators Revenue, 2024-2030
6.2.3 By Region - Global Angiogenesis Modulators Revenue Market Share, 2018-2030
6.3 By Region - Global Angiogenesis Modulators Sales & Forecasts
6.3.1 By Region - Global Angiogenesis Modulators Sales, 2018-2023
6.3.2 By Region - Global Angiogenesis Modulators Sales, 2024-2030
6.3.3 By Region - Global Angiogenesis Modulators Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Angiogenesis Modulators Revenue, 2018-2030
6.4.2 By Country - North America Angiogenesis Modulators Sales, 2018-2030
6.4.3 US Angiogenesis Modulators Market Size, 2018-2030
6.4.4 Canada Angiogenesis Modulators Market Size, 2018-2030
6.4.5 Mexico Angiogenesis Modulators Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Angiogenesis Modulators Revenue, 2018-2030
6.5.2 By Country - Europe Angiogenesis Modulators Sales, 2018-2030
6.5.3 Germany Angiogenesis Modulators Market Size, 2018-2030
6.5.4 France Angiogenesis Modulators Market Size, 2018-2030
6.5.5 U.K. Angiogenesis Modulators Market Size, 2018-2030
6.5.6 Italy Angiogenesis Modulators Market Size, 2018-2030
6.5.7 Russia Angiogenesis Modulators Market Size, 2018-2030
6.5.8 Nordic Countries Angiogenesis Modulators Market Size, 2018-2030
6.5.9 Benelux Angiogenesis Modulators Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Angiogenesis Modulators Revenue, 2018-2030
6.6.2 By Region - Asia Angiogenesis Modulators Sales, 2018-2030
6.6.3 China Angiogenesis Modulators Market Size, 2018-2030
6.6.4 Japan Angiogenesis Modulators Market Size, 2018-2030
6.6.5 South Korea Angiogenesis Modulators Market Size, 2018-2030
6.6.6 Southeast Asia Angiogenesis Modulators Market Size, 2018-2030
6.6.7 India Angiogenesis Modulators Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Angiogenesis Modulators Revenue, 2018-2030
6.7.2 By Country - South America Angiogenesis Modulators Sales, 2018-2030
6.7.3 Brazil Angiogenesis Modulators Market Size, 2018-2030
6.7.4 Argentina Angiogenesis Modulators Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Angiogenesis Modulators Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Angiogenesis Modulators Sales, 2018-2030
6.8.3 Turkey Angiogenesis Modulators Market Size, 2018-2030
6.8.4 Israel Angiogenesis Modulators Market Size, 2018-2030
6.8.5 Saudi Arabia Angiogenesis Modulators Market Size, 2018-2030
6.8.6 UAE Angiogenesis Modulators Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Celgene Corporation (USA)
7.1.1 Celgene Corporation (USA) Company Summary
7.1.2 Celgene Corporation (USA) Business Overview
7.1.3 Celgene Corporation (USA) Angiogenesis Modulators Major Product Offerings
7.1.4 Celgene Corporation (USA) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.1.5 Celgene Corporation (USA) Key News & Latest Developments
7.2 Eisai (Japan)
7.2.1 Eisai (Japan) Company Summary
7.2.2 Eisai (Japan) Business Overview
7.2.3 Eisai (Japan) Angiogenesis Modulators Major Product Offerings
7.2.4 Eisai (Japan) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.2.5 Eisai (Japan) Key News & Latest Developments
7.3 Amgen, Inc. (USA)
7.3.1 Amgen, Inc. (USA) Company Summary
7.3.2 Amgen, Inc. (USA) Business Overview
7.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Major Product Offerings
7.3.4 Amgen, Inc. (USA) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.3.5 Amgen, Inc. (USA) Key News & Latest Developments
7.4 Genentech, Inc. (USA)
7.4.1 Genentech, Inc. (USA) Company Summary
7.4.2 Genentech, Inc. (USA) Business Overview
7.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Major Product Offerings
7.4.4 Genentech, Inc. (USA) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.4.5 Genentech, Inc. (USA) Key News & Latest Developments
7.5 GlaxoSmithKline plc (UK)
7.5.1 GlaxoSmithKline plc (UK) Company Summary
7.5.2 GlaxoSmithKline plc (UK) Business Overview
7.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Major Product Offerings
7.5.4 GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline plc (UK) Key News & Latest Developments
7.6 Bayer Pharma AG (Germany)
7.6.1 Bayer Pharma AG (Germany) Company Summary
7.6.2 Bayer Pharma AG (Germany) Business Overview
7.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Major Product Offerings
7.6.4 Bayer Pharma AG (Germany) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.6.5 Bayer Pharma AG (Germany) Key News & Latest Developments
7.7 Bionomics Ltd. (Australia)
7.7.1 Bionomics Ltd. (Australia) Company Summary
7.7.2 Bionomics Ltd. (Australia) Business Overview
7.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Major Product Offerings
7.7.4 Bionomics Ltd. (Australia) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.7.5 Bionomics Ltd. (Australia) Key News & Latest Developments
7.8 CASI Pharmaceuticals, Inc. (USA)
7.8.1 CASI Pharmaceuticals, Inc. (USA) Company Summary
7.8.2 CASI Pharmaceuticals, Inc. (USA) Business Overview
7.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Major Product Offerings
7.8.4 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.8.5 CASI Pharmaceuticals, Inc. (USA) Key News & Latest Developments
7.9 AstraZeneca plc (UK)
7.9.1 AstraZeneca plc (UK) Company Summary
7.9.2 AstraZeneca plc (UK) Business Overview
7.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Major Product Offerings
7.9.4 AstraZeneca plc (UK) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.9.5 AstraZeneca plc (UK) Key News & Latest Developments
7.10 Eli Lilly and Company (USA)
7.10.1 Eli Lilly and Company (USA) Company Summary
7.10.2 Eli Lilly and Company (USA) Business Overview
7.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Major Product Offerings
7.10.4 Eli Lilly and Company (USA) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.10.5 Eli Lilly and Company (USA) Key News & Latest Developments
7.11 F.Hoffmann-La Roche AG (Switzerland)
7.11.1 F.Hoffmann-La Roche AG (Switzerland) Company Summary
7.11.2 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Business Overview
7.11.3 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Major Product Offerings
7.11.4 F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales and Revenue in Global (2018-2023)
7.11.5 F.Hoffmann-La Roche AG (Switzerland) Key News & Latest Developments
8 Global Angiogenesis Modulators Production Capacity, Analysis
8.1 Global Angiogenesis Modulators Production Capacity, 2018-2030
8.2 Angiogenesis Modulators Production Capacity of Key Manufacturers in Global Market
8.3 Global Angiogenesis Modulators Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Angiogenesis Modulators Supply Chain Analysis
10.1 Angiogenesis Modulators Industry Value Chain
10.2 Angiogenesis Modulators Upstream Market
10.3 Angiogenesis Modulators Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Angiogenesis Modulators Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Angiogenesis Modulators in Global Market
Table 2. Top Angiogenesis Modulators Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Angiogenesis Modulators Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Angiogenesis Modulators Revenue Share by Companies, 2018-2023
Table 5. Global Angiogenesis Modulators Sales by Companies, (K MT), 2018-2023
Table 6. Global Angiogenesis Modulators Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Angiogenesis Modulators Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Angiogenesis Modulators Product Type
Table 9. List of Global Tier 1 Angiogenesis Modulators Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Angiogenesis Modulators Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Angiogenesis Modulators Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Angiogenesis Modulators Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Angiogenesis Modulators Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Angiogenesis Modulators Sales (K MT), 2018-2023
Table 15. By Type - Global Angiogenesis Modulators Sales (K MT), 2024-2030
Table 16. By Application ? Global Angiogenesis Modulators Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Angiogenesis Modulators Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Angiogenesis Modulators Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Angiogenesis Modulators Sales (K MT), 2018-2023
Table 20. By Application - Global Angiogenesis Modulators Sales (K MT), 2024-2030
Table 21. By Region ? Global Angiogenesis Modulators Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Angiogenesis Modulators Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Angiogenesis Modulators Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Angiogenesis Modulators Sales (K MT), 2018-2023
Table 25. By Region - Global Angiogenesis Modulators Sales (K MT), 2024-2030
Table 26. By Country - North America Angiogenesis Modulators Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Angiogenesis Modulators Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Angiogenesis Modulators Sales, (K MT), 2018-2023
Table 29. By Country - North America Angiogenesis Modulators Sales, (K MT), 2024-2030
Table 30. By Country - Europe Angiogenesis Modulators Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Angiogenesis Modulators Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Angiogenesis Modulators Sales, (K MT), 2018-2023
Table 33. By Country - Europe Angiogenesis Modulators Sales, (K MT), 2024-2030
Table 34. By Region - Asia Angiogenesis Modulators Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Angiogenesis Modulators Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Angiogenesis Modulators Sales, (K MT), 2018-2023
Table 37. By Region - Asia Angiogenesis Modulators Sales, (K MT), 2024-2030
Table 38. By Country - South America Angiogenesis Modulators Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Angiogenesis Modulators Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Angiogenesis Modulators Sales, (K MT), 2018-2023
Table 41. By Country - South America Angiogenesis Modulators Sales, (K MT), 2024-2030
Table 42. By Country - Middle East & Africa Angiogenesis Modulators Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Angiogenesis Modulators Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Angiogenesis Modulators Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Angiogenesis Modulators Sales, (K MT), 2024-2030
Table 46. Celgene Corporation (USA) Company Summary
Table 47. Celgene Corporation (USA) Angiogenesis Modulators Product Offerings
Table 48. Celgene Corporation (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. Celgene Corporation (USA) Key News & Latest Developments
Table 50. Eisai (Japan) Company Summary
Table 51. Eisai (Japan) Angiogenesis Modulators Product Offerings
Table 52. Eisai (Japan) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. Eisai (Japan) Key News & Latest Developments
Table 54. Amgen, Inc. (USA) Company Summary
Table 55. Amgen, Inc. (USA) Angiogenesis Modulators Product Offerings
Table 56. Amgen, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Amgen, Inc. (USA) Key News & Latest Developments
Table 58. Genentech, Inc. (USA) Company Summary
Table 59. Genentech, Inc. (USA) Angiogenesis Modulators Product Offerings
Table 60. Genentech, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Genentech, Inc. (USA) Key News & Latest Developments
Table 62. GlaxoSmithKline plc (UK) Company Summary
Table 63. GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Offerings
Table 64. GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. GlaxoSmithKline plc (UK) Key News & Latest Developments
Table 66. Bayer Pharma AG (Germany) Company Summary
Table 67. Bayer Pharma AG (Germany) Angiogenesis Modulators Product Offerings
Table 68. Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Bayer Pharma AG (Germany) Key News & Latest Developments
Table 70. Bionomics Ltd. (Australia) Company Summary
Table 71. Bionomics Ltd. (Australia) Angiogenesis Modulators Product Offerings
Table 72. Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Bionomics Ltd. (Australia) Key News & Latest Developments
Table 74. CASI Pharmaceuticals, Inc. (USA) Company Summary
Table 75. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Offerings
Table 76. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. CASI Pharmaceuticals, Inc. (USA) Key News & Latest Developments
Table 78. AstraZeneca plc (UK) Company Summary
Table 79. AstraZeneca plc (UK) Angiogenesis Modulators Product Offerings
Table 80. AstraZeneca plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. AstraZeneca plc (UK) Key News & Latest Developments
Table 82. Eli Lilly and Company (USA) Company Summary
Table 83. Eli Lilly and Company (USA) Angiogenesis Modulators Product Offerings
Table 84. Eli Lilly and Company (USA) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. Eli Lilly and Company (USA) Key News & Latest Developments
Table 86. F.Hoffmann-La Roche AG (Switzerland) Company Summary
Table 87. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Product Offerings
Table 88. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 89. F.Hoffmann-La Roche AG (Switzerland) Key News & Latest Developments
Table 90. Angiogenesis Modulators Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 91. Global Angiogenesis Modulators Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Angiogenesis Modulators Production by Region, 2018-2023 (K MT)
Table 93. Global Angiogenesis Modulators Production by Region, 2024-2030 (K MT)
Table 94. Angiogenesis Modulators Market Opportunities & Trends in Global Market
Table 95. Angiogenesis Modulators Market Drivers in Global Market
Table 96. Angiogenesis Modulators Market Restraints in Global Market
Table 97. Angiogenesis Modulators Raw Materials
Table 98. Angiogenesis Modulators Raw Materials Suppliers in Global Market
Table 99. Typical Angiogenesis Modulators Downstream
Table 100. Angiogenesis Modulators Downstream Clients in Global Market
Table 101. Angiogenesis Modulators Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Angiogenesis Modulators Segment by Type in 2022
Figure 2. Angiogenesis Modulators Segment by Application in 2022
Figure 3. Global Angiogenesis Modulators Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Angiogenesis Modulators Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Angiogenesis Modulators Revenue, 2018-2030 (US$, Mn)
Figure 7. Angiogenesis Modulators Sales in Global Market: 2018-2030 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Angiogenesis Modulators Revenue in 2022
Figure 9. By Type - Global Angiogenesis Modulators Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Angiogenesis Modulators Revenue Market Share, 2018-2030
Figure 11. By Type - Global Angiogenesis Modulators Sales Market Share, 2018-2030
Figure 12. By Type - Global Angiogenesis Modulators Price (USD/MT), 2018-2030
Figure 13. By Application - Global Angiogenesis Modulators Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Angiogenesis Modulators Revenue Market Share, 2018-2030
Figure 15. By Application - Global Angiogenesis Modulators Sales Market Share, 2018-2030
Figure 16. By Application - Global Angiogenesis Modulators Price (USD/MT), 2018-2030
Figure 17. By Region - Global Angiogenesis Modulators Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Angiogenesis Modulators Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Angiogenesis Modulators Revenue Market Share, 2018-2030
Figure 20. By Region - Global Angiogenesis Modulators Sales Market Share, 2018-2030
Figure 21. By Country - North America Angiogenesis Modulators Revenue Market Share, 2018-2030
Figure 22. By Country - North America Angiogenesis Modulators Sales Market Share, 2018-2030
Figure 23. US Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Angiogenesis Modulators Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Angiogenesis Modulators Sales Market Share, 2018-2030
Figure 28. Germany Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 29. France Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Angiogenesis Modulators Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Angiogenesis Modulators Sales Market Share, 2018-2030
Figure 37. China Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 41. India Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Angiogenesis Modulators Revenue Market Share, 2018-2030
Figure 43. By Country - South America Angiogenesis Modulators Sales Market Share, 2018-2030
Figure 44. Brazil Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Angiogenesis Modulators Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Angiogenesis Modulators Sales Market Share, 2018-2030
Figure 48. Turkey Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Angiogenesis Modulators Revenue, (US$, Mn), 2018-2030
Figure 52. Global Angiogenesis Modulators Production Capacity (K MT), 2018-2030
Figure 53. The Percentage of Production Angiogenesis Modulators by Region, 2022 VS 2030
Figure 54. Angiogenesis Modulators Industry Value Chain
Figure 55. Marketing Channels
